October 25, 2014 7:47 PM ET

Capital Markets

Company Overview of Canaccord Genuity Inc.

Company Overview

Canaccord Genuity Inc. is an investment banking firm that provides financial advisory services. The firm offers mergers and acquisitions advisory, divestitures, recapitalizations, valuations, fairness opinions, private placements, private capital raising, and valuation analysis services. Additionally, it provides underwriting, Initial Public Offering (IPO), and equity sales and trading services. The firm caters to metals and mining, energy, technology, telecommunications, life sciences, real estate, and aerospace industries. Canaccord Adams, formerly known as Adams Harkness, Inc., was founded in 1969 and is based in Boston, Massachusetts with additional offices across the United States. Cana...

99 High Street

Suite 1200

Boston, MA 02110

United States

Founded in 1969

Phone:

617-371-3900

Key Executives for Canaccord Genuity Inc.

President
Chief Financial Officer and Treasurer
Chairman of The Board
Age: 57
Principal
Managing Director
Compensation as of Fiscal Year 2014.

Canaccord Genuity Inc. Key Developments

Marko Kozul Agrees to Join Canaccord Genuity's Equity Research Team as a Managing Director Covering Biotechnology Companies

Canaccord Genuity announced that Marko Kozul, M.D. has agreed to join its Equity Research team as a Managing Director covering biotechnology companies. Based in the firm's San Francisco office, Dr. Kozul will focus on companies with advanced biotechnology platforms in the areas of neurology, immunology, obesity, oncology, and orphan infectious diseases. He joins senior Healthcare analysts John Newman and Corey Davis, building upon the firm's existing US life science practice. Dr. Kozul joins Canaccord Genuity from Leerink Partners where he served as a senior biotechnology analyst and was previously analyst at ThinkEquity Partners and Jefferies & Company.

Canaccord Genuity Inc. Presents at 2014 Bioshares Biotech Summit, Jul-18-2014 05:20 PM

Canaccord Genuity Inc. Presents at 2014 Bioshares Biotech Summit, Jul-18-2014 05:20 PM. Venue: Rydges Lakeland Resort, Queenstown, New Zealand. Speakers: Matthijs Smith, Healthcare Analyst.

Canaccord Genuity Hires Corey Davis as Managing Director

Canaccord Genuity announced the expansion of its Healthcare Equity Research team with the hiring of Corey Davis, Ph.D., as a Managing Director covering Specialty Pharmaceuticals, with a focus in certain therapeutics areas within the biotech sector. Mr. Davis brings over 16 years of sell-side experience covering Specialty Pharmaceuticals companies, most of those years at JP Morgan and at Jefferies. He is widely recognized for his expertise on a broad range of key issues within the industry, including IP law, CNS-related disorders, clinical trial design, financial modelling, and has deep relationships with thought leaders in the industry. At Canaccord Genuity, Corey will establish strong coverage of key Specialty Pharmaceuticals names, as well as a series of later-stage biopharmaceutical companies that offer investors a broad range of investment opportunities in drug development.

Similar Private Companies By Industry

Company Name Region
Churchill Capital USA, Inc. United States
TM Capital Corp., Research Division United States
Citigroup Global Capital Markets Inc. United States
Resource Innovation Capital United States
Kuhn Capital United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Canaccord Genuity Inc., please visit www.canaccordgenuity.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.